Alberico L Catapano Selected Research

Hypercholesterolemia

5/2022	Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials.
1/2022	New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemia.
1/2021	Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study).
1/2021	Role of Bempedoic Acid in Clinical Practice.
12/2020	Hypercholesterolemia and cardiovascular disease: What to do before initiating pharmacological therapy.
12/2020	Hypercholesterolemia and cardiovascular disease: Focus on high cardiovascular risk patients.
10/2020	Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia.
9/2020	Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials.
1/2020	Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy.
1/2020	New Pharmacological Approaches to Target PCSK9.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberico L Catapano Research Topics

Disease

64	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 06/2003
25	Atherosclerosis 05/2022 - 06/2003
24	Hypercholesterolemia 05/2022 - 10/2004
20	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 03/2015
12	Dyslipidemias (Dyslipidemia) 12/2020 - 02/2010
12	Coronary Disease (Coronary Heart Disease) 10/2020 - 12/2003
11	Myocardial Infarction 12/2022 - 05/2002
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2021 - 04/2008
7	Stroke (Strokes) 10/2020 - 04/2005
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2007
6	Homozygous Familial Hypercholesterolemia 01/2022 - 08/2014
5	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 02/2018
5	Inflammation (Inflammations) 10/2020 - 12/2010
4	Atherosclerotic Plaque (Atheroma) 12/2022 - 07/2003
4	Pancreatitis 10/2021 - 08/2014
4	Vascular Diseases (Vascular Disease) 01/2021 - 12/2009
4	Acute Coronary Syndrome 12/2020 - 11/2012
4	Insulin Resistance 01/2020 - 10/2007
4	Neoplasms (Cancer) 01/2020 - 04/2013
4	Diabetes Mellitus 01/2018 - 05/2015
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022 - 09/2015
3	Prediabetic State (Prediabetes) 01/2022 - 12/2016
3	Peripheral Arterial Disease 12/2021 - 01/2018
3	Gout 10/2020 - 01/2019
3	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 04/2017 - 05/2015
3	Muscular Diseases (Myopathy) 01/2017 - 06/2011
3	Hypertension (High Blood Pressure) 06/2016 - 10/2007
2	Dementia (Dementias) 01/2022 - 10/2013
2	Ischemic Stroke 12/2021 - 11/2014
2	Hemorrhage 12/2021 - 11/2021
2	Overweight 05/2021 - 12/2015
2	Chronic Renal Insufficiency 12/2020 - 07/2020
2	Death (Near-Death Experience) 10/2020 - 12/2013
2	Myalgia 09/2020 - 05/2015
2	Hypotension (Low Blood Pressure) 01/2020 - 10/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 02/2010
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020 - 01/2018
2	Infections 12/2019 - 10/2016
2	Cataract (Cataracts) 01/2019 - 01/2018
2	Heart Failure 01/2018 - 02/2010
2	Hypertriglyceridemia 10/2015 - 08/2013
2	Xanthomatosis (Xanthoma) 08/2014 - 12/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 11/2007 - 05/2002
1	Chronic Disease (Chronic Diseases) 05/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Cognitive Dysfunction 01/2022
1	Vascular Calcification 01/2022

Drug/Important Bio-Agent (IBA)

41	oxidized low density lipoproteinIBA 05/2022 - 05/2002
40	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 05/2002
40	LipidsIBA 01/2022 - 06/2003
36	LDL CholesterolIBA 05/2022 - 12/2003
23	CholesterolIBA 12/2022 - 05/2002
14	HDL CholesterolIBA 10/2021 - 08/2007
13	Lipoproteins (Lipoprotein)IBA 01/2022 - 10/2007
11	Ezetimibe (Zetia)FDA Link 01/2022 - 10/2006
10	Triglycerides (Triacylglycerol)IBA 12/2021 - 10/2007
9	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 05/2022 - 01/2019
7	ApolipoproteinsIBA 01/2022 - 10/2007
7	Apolipoproteins B (ApoB)IBA 01/2022 - 10/2007
6	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 03/2006
6	Simvastatin (Zocor)FDA LinkGeneric 06/2016 - 10/2006
5	Pharmaceutical PreparationsIBA 01/2022 - 02/2010
5	Monoclonal AntibodiesIBA 01/2022 - 01/2019
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2007
5	HDL LipoproteinsIBA 01/2018 - 07/2003
4	Proprotein Convertase 9IBA 01/2021 - 12/2016
4	C-Reactive ProteinIBA 01/2021 - 12/2008
4	EnzymesIBA 10/2020 - 03/2006
4	Fibric Acids (Fibrates)IBA 01/2019 - 06/2011
4	Atorvastatin (Lipitor)FDA Link 10/2013 - 04/2008
4	Rosuvastatin Calcium (Crestor)FDA Link 12/2009 - 10/2006
3	Lipoprotein(a)IBA 01/2022 - 03/2015
3	evinacumabIBA 01/2022 - 12/2020
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2021 - 11/2012
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 10/2018
3	LDL Receptors (LDL Receptor)IBA 11/2020 - 02/2012
3	lipoprotein cholesterolIBA 01/2020 - 10/2007
3	mipomersenIBA 01/2019 - 08/2014
3	Pravastatin (Pravachol)FDA LinkGeneric 11/2017 - 03/2013
2	RivaroxabanIBA 12/2021 - 11/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
2	Fenofibrate (CiL)FDA LinkGeneric 01/2021 - 04/2016
2	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 11/2014
2	Uric Acid (Urate)IBA 10/2020 - 06/2011
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2020 - 08/2013
2	alirocumabIBA 01/2020 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 12/2009
2	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2019 - 12/2003
2	Apolipoproteins E (ApoE)IBA 01/2018 - 10/2017
2	IncretinsIBA 01/2017 - 05/2015
2	Niacin (Nicotinic Acid)FDA LinkGeneric 11/2014 - 06/2011
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2008 - 10/2007
2	HomocysteineIBA 11/2007 - 05/2002
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2007 - 05/2002
1	Scavenger Receptors (Scavenger Receptor)IBA 12/2022
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 12/2022
1	Phosphates (Orthophosphate)IBA 01/2022

Therapy/Procedure

32	Therapeutics 12/2021 - 01/2008
5	Secondary Prevention 01/2021 - 09/2005
1	Mediterranean Diet 05/2022